|Last Price||Today's Change||52-Week Range||Trading Volume|
|8.50 CAD||-0.24 (-2.75%)||4.80 - 9.47||376.0 (Below Avg)|
Market data as of 3:50PM 03/27/15. Quotes are delayed by at least 15 min.
Transition Therapeutics Announces Results from Phase 1 AME & Renal Clearance Clinical Studies of Neuropsychiatric Drug Candidate ELND005
PR Newswire - Thursday 03/26/2015 6:01 AM ET
Transition Therapeutics Announces Enrolment Completion of ELND005 Phase 2 Clinical Study in Agitation and Aggression in Patients with Alzheimer's Disease
PR Newswire - Monday 03/02/2015 6:02 AM ET
|Revenue Growth (1yr)||--|
|Net Income Growth (1yr)||--|
Data is delayed by at least 15 min.